Here, we found that the expression of Nrf2 in AML patients with gene mutation was significantly higher than that in non-mutated groups by Western blotting and RT-qPCR (P < 0.05, Fig. 2A-C). This evidence concerns the gene NFE2L2 and acute myeloid leukemia.